Abstract
30-40% of patients with major depression do not respond to multiple trials of antidepressant drugs and augmentation agents. This is a retrospective evaluation of the efficacy of rTMS in severely treatment-resistant patients in a private outpatient practice.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
